This company listing is no longer active
9 Meters Biopharma Balance Sheet Health
Financial Health criteria checks 0/6
9 Meters Biopharma has a total shareholder equity of $-6.3M and total debt of $5.1M, which brings its debt-to-equity ratio to -80.5%. Its total assets and total liabilities are $9.3M and $15.6M respectively.
Key information
-80.5%
Debt to equity ratio
US$5.07m
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.94m |
| Equity | -US$6.30m |
| Total liabilities | US$15.61m |
| Total assets | US$9.31m |
Recent financial health updates
Recent updates
9 Meters Biopharma to execute 1-for-20 reverse stock split
Oct 179 Meters Biopharma GAAP EPS of -$0.04 in-line
Aug 159 meters launches Phase 2 VIBRANT study of vurolenatide for short bowel syndrome
Jun 149 Meters drug effective in treating rare COVID-19 complication in children
May 269 Meters Bio gains 5% on Adage Capital stake disclosure
Dec 299 Meters Biopharma slumps, continues evaluation of Larazotide for COVID-19 respiratory complications
Dec 219 Meters Bio launches equity offering
Dec 11Financial Position Analysis
Short Term Liabilities: NMTR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NMTR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NMTR has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NMTR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NMTR has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NMTR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.4% each year